Simon Leboube

Cardiologist @CHUdeLyon PhD student in IRIS Team @CarMeN_lab_lyon

[thomas.bochaton @BochatonThomas]

Glad to be back at #aha2022 in Chicago with my colleagues @sleboube @PaillardMel @GomezLudovik @CHUdeLyon @HCL_research @LaboratoryIris

[LDLC ASVEL @LDLCASVEL]

🙏 Dans le cadre des Journées de l’Avenir organisées dans tous les clubs de LNB, Gaëtan Muller, Alain Béral, Président de la @LNBofficiel et Marion Lelouvier, Présidente de la @FondationAvenir, remettent le chèque à Mélanie Paillard, chercheuse à l’hôpital Lyon Sud !

#LDLCASVEL

[IRIS Team Carmen Laboratory @LaboratoryIris]

Félicitations au Professeur Marco Vola du GHE cardiologie des Hospices Civils de Lyon pour l’obtention de son projets RHU (Recherche Hospitalo-Universitaire en santé) : « ICELAND »
@HCL_research @CarMeN_lab_Lyon @InsermAuRA @CHUdeLyon

[baetz delphine @BaetzDelphine]

les Journées de l'Avenir !
L'équipe Lyonnaise @LaboratoryIris a été sélectionnée pour ses recherches dans le domaine cardiovasculaire par la LNB @LNBofficiel et à la @FondationAvenir pour faire avancer la recherche médicale
https://t.co/L3ffClYvQu
merci de diffuser

[Ahmad Hayek @AhmadHayek0]

From @jaccjournals https://t.co/kyQkQKgaqT
Check our latest article! @BochatonThomas @mewton_nathan @CHUdeLyon @alexPaccalet

[thomas.bochaton @BochatonThomas]

Our latest article: Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era of mechanical rep… https://t.co/TeSmF2UkH2
@alexPaccalet @crola_da @mewton_nathan @sleboube

[IRIS Team Carmen Laboratory @LaboratoryIris]

After his excellent thesis defense, Alexandre Paccalet is now in Nahrendorf laboratory (Harvard University, Boston) for his post-doctoral fellowship, Good luck in your future research Alex!
@LaboratoryIris @CarMeN_lab_Lyon @MatthiasNahrend @alexPaccalet @HCL_research @Inserm

[thomas.bochaton @BochatonThomas]

Serum soluble Tumor Necrosis Factor Receptor (sTNFR) 1 and 2 are early prognosis markers after STEMI https://t.co/Att5uS3nKf @alexPaccalet @crola_da @sleboube @mewton_nathan @CHUdeLyon @Inserm @LaboratoryIris

[Ahmad Hayek @AhmadHayek0]

Transcatheter mitral valve repair to treat postmyocardial infarction papillary muscle rupture Hayek A, Grinberg D, Derimay F, Bochaton T - J Cardiovasc Echography https://t.co/SL8T9whXMD @BochatonThomas @dnlgrinberg @CHUdeLyon

[Ahmad Hayek @AhmadHayek0]

Acute pulmonary embolism and thrombus entrapped in the patent foramen ovale in a patient with COVID-19 Hayek A, Flagiello M, Aubry M, Bochaton T - J Cardiovasc Echography https://t.co/DdIIdt9WMI

[IRIS Team Carmen Laboratory @LaboratoryIris]

📣Great news for our PhD student @alexPaccalet, who recently got supported by @Servier Institute for his post-doctoral project in @Harvard! 📝 @CarMeN_lab_Lyon @HCL_research @InsermAuRA

[Simon Leboube @sleboube]

Soluble C-Met is a biomarker of clinical outcomes after STEMI
From @jaccjournals https://t.co/6XwZHpFFib
@BochatonThomas @alexPaccalet @crola_da @mewton_nathan @CHUdeLyon @LaboratoryIris @fedecardio @AngoulvantD

[IRIS Team Carmen Laboratory @LaboratoryIris]

Our Phd student have something to say about myocardial ischemia-reperfusion injury and diabetes!! !! 🫀💊 https://t.co/L4ASgwW6pD
@MayaDia1 @alexPaccalet @crola_da @BochatonThomas @CarMeN_lab_Lyon @FrontiersIn @InsermAuRA @HCL_research #cardiotwitter

[thomas.bochaton @BochatonThomas]

Our last article:
Kinetics and prognostic value of soluble VCAM‐1 in ST‐segment elevation myocardial infarction patients https://t.co/QQ8U3SIDTj @AhmadHayek0 @mewton_nathan @crola_da @alexPaccalet @FabriceIvanes @CHUdeLyon @CarMeN_lab_Lyon @Inserm

[Paccalet Alexandre @alexPaccalet]

Hey #cardiotwitter 📣 RIFIFI study is out 📣

Myocardial hemorrhage present a strongest relationship with inflammatory biomarkers release compare to persistant MVO or edema in STEMI patients 🫀🔥
@BochatonThomas @mewton_nathan @CarMeN_lab_Lyon @CHUdeLyon

[Paccalet Alexandre @alexPaccalet]

Hsp-70 as a biomarker of Clinical outcomes after STEMI. @JACCJournals @BochatonThomas @ovizem @CHUdeLyon @mewton_nathan https://t.co/mGNQJ64lVo….